SCHEMBL20072255

SCHEMBL20072255

CC(S)c1ccc(Cl)cc1C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.40
TP53 P04637 2/20 0.40
LMNA P02545 1/20 0.40
PDE2A O00408 2/20 0.39
P2RX7 Q99572 1/20 0.39
RAB9A P51151 3/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
PAX8 Q06710 1/20 0.36
POLQ O75417 1/20 0.35
MAPT P10636 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KDM4E B2RXH2 1/20 0.34
CCR2 P41597 1/20 0.34
HSD11B1 P28845 2/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10039365 0.85 NOTUM (0.43) HTTTP53LMNAPDE2AP2RX7
SCHEMBL14992787 0.81 HTT (0.58) HTTTP53LMNAPDE2AP2RX7
SCHEMBL27851290 0.81 P2RX7 (0.54) HTTTP53LMNAPDE2AP2RX7
SCHEMBL7718011 0.81 HTT (0.58) HTTTP53LMNAPDE2AP2RX7
SCHEMBL20072377 0.79 PDE2A (0.47) PDE2AALDH1A1POLQ
SCHEMBL20368390 0.79 TRPA1 (0.38) LMNAPDE2AP2RX7SMN1; SMN2
SCHEMBL1721409 0.79 PDE2A (0.51) HTTTP53LMNAPDE2AP2RX7
SCHEMBL21725462 0.79 AR (0.39) HTTTP53LMNAPDE2AP2RX7
SCHEMBL7804287 0.79 RAB9A (0.40) HTTTP53LMNAPDE2AP2RX7
SCHEMBL11603191 0.79 RAB9A (0.40) HTTTP53LMNAPDE2AP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11225469-B2 Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2022-01-18 US disclosed
US-20180105508-A1 INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11225469-B2 Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof PHGDH, PGD, PGK1 HTT 3947/4885TP53 297/4885LMNA 3874/4885
US-20180105508-A1 INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF PHGDH, PGD, PGK1 HTT 4018/4885TP53 245/4885LMNA 3829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.